Bio-Technology is a huge field of positives and negatives. The positives would be from the advancement in the fight against cancer and the negatives would be from the companies that are only looking for a quick buck. One of the most, if not the most successful bio-technology company in the world, Seattle Genetics is pushing well beyond the limits of any other in it’s field of work. The company is headed by Dr. Clay Siegell whom is a revolutionary when it comes to the development and commercialization of pharmaceutical cancer medications. He is a very accomplished doctor as he sports a Ph.D in Genetics from the prestigious George Washington University and a B.S. in Zoology from the University of Maryland. Siegell is the heart and brains of this business and continuing to push the company even further into the future.
Dr. Clay Siegel has worked for many prominent corporations such as Bristol-Myers Squibb, National Institute of Health, and National Cancer Institute before the genesis of Seattle Genetics. Currently this super power is building for the future and has many new products on tap, an increase in staff and infrastructure. Seattle Genetics specializes in (ADC) and (SEA)Technology. The company posts significant amounts of their research and trials unlike the competitors. The company’s (ADCs) deliver cell killing agents straight to cancer cells and their (SEAs) compliment it by increasing the potency of monoclonal antibodies. It’s one, two punch for cancer cells that is really effective and causes positive results in patients. To keep from being too medical technical, here are some of the products currently in the works for fighting cancer:
As stated above, these pharmaceuticals are designed for the fight against cancer and each medicine treats different cancerous forms. As you can see, this is just a sliver what Seattle Genetics is capable of and Dr. Clay Siegel is on board for the long run so the general public can expect bigger and better things in the near future.